Arno H. Werners, DVM, PhD, DECVPT

Arno H. Werners, DVM, PhD, DECVPT
Professor of Pharmacology
Email: awerners@sgu.edu
Website: http://www.sgu.edu
Phone: (473) 444-4175 ext. 3336



Biography

Click here to view complete Curriculum Vitae

Dr. Arno Werners obtained his DVM degree from the Faculty of Veterinary Medicine, Utrecht University in 1999. He stayed at Utrecht as a junior lecturer and researcher in veterinary pharmacology and toxicology and combined his work at Utrecht with a position at an equine referral practice focusing on equine respiratory diseases.

He enrolled in both a PhD program studying the molecular mechanisms and therapeutic interventions of equine endotoxemia and in a residency in veterinary pharmacology and toxicology. Both programs were completed in 2005, after which he joined the equine medicine team in the clinic of the Department of Equine Sciences at Utrecht University for a residency program in equine internal medicine. After a brief spell at the pharmacology and toxicology section, Dr. Werners accepted a position at the University of Cambridge in 2010, before moving to St. George’s, Grenada to head the pharmacology section at the school of veterinary medicine. Dr. Werners obtained a Utrecht University teaching degree in 2009 and has been teaching basic and clinical pharmacology for over 10 years.

Areas of Interest
Innate Immunity, (Equine) Clinical Pharmacology
Affiliations
Selected Publications

Werners, AH; Bull, S; Vendrig, JC; Smyth, T; Bosch, RR; Fink-Gremmels, J; Bryant, CE (2006). “Genotyping of Toll-like receptor 4, myeloid differentiation factor 2 and CD14 in the horse: The influence of genetic polymorphisms on the LPS response in equine whole blood”. Veterinary Immunology and Immunopathology 111: 165-173

Werners, AH; Bull, S; Fink-Gremmels, J (2005). “Endotoxaemia, a review with implications for the horse”. Equine Veterinary Journal 37 (4): 371-383

Werners, AH; Bull, S; Fink-Gremmels, J and Bryant, CE (2004). “Generation and characterisation of an equine macrophage cell line (e-CAS) derived from equine bone marrow cells”. Veterinary Immunology and Immunopathology 97 (1-2): 65-76